fda ruling on semaglutide September 2, 2025: U.S. compounding restrictions have stemmed a flood of compounded and tirzepatide – Partnership for Safe Medicines FDA warns consumers not to

doi: 10.2147/jir.S450599 84 GorgaSMCarltonEKohneJBarbaroR

Baltzis D, Dushay JR, Loader J, Wu J, Greenman RL, Roustit M, Veves A

The FDA label recommends that women using oral hormonal contraceptives switch to a non-oral contraceptive method or add a barrier method for 4 weeks after initiation and for 4 weeks after each dose escalation of tirzepatide

Unacclimatized people, including tourists, new arrivals, and indoor workers stepping outside for the first time, lose even more

Lower Inflammation, Stronger Cells Chronic, low-grade inflammation is a driver of aging

Comparison to Other GLP-1s Retatrutides dosing strategy stands out when compared to currently available incretin-based therapies such as semaglutide and tirzepatide